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Introduction: Cancer is one of the major causes of death in many industrialized 
countries and its incidence is continually increasing. The most effective treatment 
for tumor is chemotherapy that lead to severe side effects due to their effects on 
normal non-targeted organs. Nanoparticulate carriers perform as vehicle, protecting 
the therapeutic agent from the biological milieu and improve cellular uptake and 
accumulation inside tumor sites. Chitosan nanoparticles (NPs) can be considered 
suitable vehicles for site-specific delivery of gemcitabine. Wheat germ agglutinin 
(WGA) is one of the least immunogenic lectins and putative nontoxic that has been 
demonstrated as somewhat more specific to intestinal cell lines of human origin, 
human colonocytes and prostate cancer cells. 
Methods and Results: Nanoparticles were generated by adding tripolyphosphate 
(TPP) to chitosan in acetic acid containing 1mg drug under magnet stirring and 
centrifuged at 30,000 rpm, then lyophilized. To conjugate the surface of NPs with 
WGA, NPs were incubated in tow repeatable cycles with anhydrous acetone 
containing carbonyldiimidazole (CDI). Then, the activated bead were suspended in 
borate buffer, pH 9.0 to which 0.1 mg of WGA was added under vortexing. After 
                                       -                      C. 
Gemcitabine-loaded NPs conjugated by WGA were prepared with a mean size of 
160 nm, gemcitabine encapsulation efficiency of 63% and yield of 60%. These NPs 
had superior in vitro anti proliferation activity against the Caco2 and HT29. 
Conjugated NPs in comparison with unconjugated NPs and free drug exhibit better 
selectivity for target cells and tissues. 
Conclusions: NPs conjugated WGA by enhanced cytotoxicity could be considered 
as a good candidate for oral delivery of anticancer drug. However other studies 
should be performed to evaluate in vitro test of these NPs. 
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